Free Trial

Vir Biotechnology (VIR) Competitors

Vir Biotechnology logo
$5.30 +0.03 (+0.57%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$5.30 +0.00 (+0.02%)
As of 08:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VIR vs. MOR, KYMR, IMVT, CRNX, ALVO, HCM, AMRX, CPRX, BHC, and OGN

Should you be buying Vir Biotechnology stock or one of its competitors? The main competitors of Vir Biotechnology include MorphoSys (MOR), Kymera Therapeutics (KYMR), Immunovant (IMVT), Crinetics Pharmaceuticals (CRNX), Alvotech (ALVO), HUTCHMED (HCM), Amneal Pharmaceuticals (AMRX), Catalyst Pharmaceuticals (CPRX), Bausch Health Cos (BHC), and Organon & Co. (OGN). These companies are all part of the "pharmaceutical products" industry.

Vir Biotechnology vs. Its Competitors

Vir Biotechnology (NASDAQ:VIR) and MorphoSys (NASDAQ:MOR) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

MorphoSys has higher revenue and earnings than Vir Biotechnology. MorphoSys is trading at a lower price-to-earnings ratio than Vir Biotechnology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vir Biotechnology$74.21M9.87-$521.96M-$4.22-1.26
MorphoSys$238.28M11.99-$205.35M-$3.48-5.45

65.3% of Vir Biotechnology shares are held by institutional investors. Comparatively, 18.4% of MorphoSys shares are held by institutional investors. 16.0% of Vir Biotechnology shares are held by insiders. Comparatively, 0.1% of MorphoSys shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

MorphoSys has a net margin of -226.79% compared to Vir Biotechnology's net margin of -2,769.04%. Vir Biotechnology's return on equity of -47.46% beat MorphoSys' return on equity.

Company Net Margins Return on Equity Return on Assets
Vir Biotechnology-2,769.04% -47.46% -39.33%
MorphoSys -226.79%-694.31%-22.55%

Vir Biotechnology presently has a consensus target price of $32.86, indicating a potential upside of 519.95%. Given Vir Biotechnology's stronger consensus rating and higher probable upside, equities analysts clearly believe Vir Biotechnology is more favorable than MorphoSys.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vir Biotechnology
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
MorphoSys
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Vir Biotechnology has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, MorphoSys has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.

In the previous week, Vir Biotechnology had 3 more articles in the media than MorphoSys. MarketBeat recorded 4 mentions for Vir Biotechnology and 1 mentions for MorphoSys. Vir Biotechnology's average media sentiment score of 0.74 beat MorphoSys' score of -0.71 indicating that Vir Biotechnology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vir Biotechnology
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MorphoSys
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

Summary

Vir Biotechnology beats MorphoSys on 10 of the 16 factors compared between the two stocks.

Get Vir Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VIR vs. The Competition

MetricVir BiotechnologyMED IndustryMedical SectorNASDAQ Exchange
Market Cap$728.51M$2.87B$5.50B$8.95B
Dividend YieldN/A2.45%5.25%4.04%
P/E Ratio-1.2620.8026.9720.11
Price / Sales9.87286.31425.92119.81
Price / CashN/A41.1936.8257.86
Price / Book0.637.487.985.56
Net Income-$521.96M-$55.04M$3.16B$248.40M
7 Day Performance-2.39%2.44%2.36%4.67%
1 Month Performance-2.39%1.90%2.15%6.64%
1 Year Performance-36.68%4.35%33.78%21.31%

Vir Biotechnology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VIR
Vir Biotechnology
3.1902 of 5 stars
$5.30
+0.6%
$32.86
+519.9%
-37.1%$728.51M$74.21M-1.26580Positive News
MOR
MorphoSys
N/A$18.96
flat
N/AN/A$2.86B$238.28M-5.45730
KYMR
Kymera Therapeutics
3.1715 of 5 stars
$43.81
-2.2%
$59.11
+34.9%
+35.9%$2.85B$47.07M-14.13170
IMVT
Immunovant
1.3922 of 5 stars
$16.42
-3.1%
$38.33
+133.5%
-38.9%$2.81BN/A-5.99120
CRNX
Crinetics Pharmaceuticals
3.1512 of 5 stars
$29.06
-2.5%
$71.75
+146.9%
-35.3%$2.72B$1.04M-7.61210
ALVO
Alvotech
3.9995 of 5 stars
$9.02
-1.8%
$18.00
+99.6%
-27.5%$2.72B$491.98M24.381,032
HCM
HUTCHMED
1.3216 of 5 stars
$15.42
-2.5%
$19.00
+23.2%
-4.6%$2.69B$630.20M0.001,811
AMRX
Amneal Pharmaceuticals
3.1334 of 5 stars
$8.41
-0.1%
$11.60
+37.9%
+21.0%$2.64B$2.79B-210.208,100
CPRX
Catalyst Pharmaceuticals
4.8957 of 5 stars
$20.95
-2.4%
$32.83
+56.7%
+34.3%$2.56B$491.73M13.3480
BHC
Bausch Health Cos
3.6984 of 5 stars
$6.88
-2.5%
$7.42
+7.8%
-7.9%$2.55B$9.63B-62.5520,700
OGN
Organon & Co.
4.891 of 5 stars
$9.74
-2.2%
$18.00
+84.8%
-50.6%$2.53B$6.29B3.384,000Trending News

Related Companies and Tools


This page (NASDAQ:VIR) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners